
← The Long Run with Luke Timmerman9. Sept. · 1 Std. 36 Min.
Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets
Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets
Mathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.